| 000 | 00851 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513170536.0 | ||
| 264 | 0 | _c19990601 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0301-0147 | ||
| 024 | 7 |
_a10.1159/000022395 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSamama, M M | |
| 245 | 0 | 0 |
_aThromboembolic diseases: mechanisms, prophylaxis and treatment. Concluding remarks. _h[electronic resource] |
| 260 |
_bHaemostasis _c1998 |
||
| 300 |
_a148-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aThromboembolism _xetiology |
| 773 | 0 |
_tHaemostasis _gvol. 28 Suppl 3 _gp. 148-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000022395 _zAvailable from publisher's website |
| 999 |
_c10029791 _d10029791 |
||